It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
DNA methylation is a critical regulatory mechanism implicated in development, learning, memory, and disease in the human brain. Here we have elucidated DNA methylation changes during recent human brain evolution. We demonstrate dynamic evolutionary trajectories of DNA methylation in cell-type and cytosine-context specific manner. Specifically, DNA methylation in non-CG context, namely CH methylation, has increased (hypermethylation) in neuronal gene bodies during human brain evolution, contributing to human-specific down-regulation of genes and co-expression modules. The effects of CH hypermethylation is particularly pronounced in early development and neuronal subtypes. In contrast, DNA methylation in CG context shows pronounced reduction (hypomethylation) in human brains, notably in cis-regulatory regions, leading to upregulation of downstream genes. We show that the majority of differential CG methylation between neurons and oligodendrocytes originated before the divergence of hominoids and catarrhine monkeys, and harbors strong signal for genetic risk for schizophrenia. Remarkably, a substantial portion of differential CG methylation between neurons and oligodendrocytes emerged in the human lineage since the divergence from the chimpanzee lineage and carries significant genetic risk for schizophrenia. Therefore, recent epigenetic evolution of human cortex has shaped the cellular regulatory landscape and contributed to the increased vulnerability to neuropsychiatric diseases.
DNA methylation plays an important role in brain development and function. Here, the authors compare whole-genome methylation in neurons and oligodendrocytes in humans, chimpanzees and macaques to reconstruct evolution of DNA methylation at cell-type level, including in regions associated with schizophrenia heritability.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 School of Biological Sciences, Georgia Institute of Technology, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943)
2 School of Biological Sciences, Georgia Institute of Technology, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943); Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain (GRID:grid.420175.5) (ISNI:0000 0004 0639 2420)
3 UT Southwestern Medical Center, Department of Neuroscience, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)
4 UT Southwestern Medical Center, Department of Neuroscience, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); Osaka University, Suita, Center for Medical Research and Education and Department of Neuroscience and Cell Biology, Graduate School of Medicine, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
5 UT Southwestern Medical Center, Department of Neuroscience, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); Tokyo Metropolitan Institute of Medical Science, Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo, Japan (GRID:grid.272456.0)
6 School of Biological Sciences, Georgia Institute of Technology, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943); Seoul National University, College of Nursing and The Research Institute of Nursing Science, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
7 Yerkes National Primate Research Center, Emory University, Division of Neuropharmacology and Neurologic Diseases, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502); Emory University School of Medicine, Department of Pathology, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)